Re-expression of ER in Triple Negative Breast Cancers
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Tumors|Breast Neoplasms
Interventions: DRUG: Decitabine, LBH589, Tamoxifen
Sponsor: Emory University
Collaborators: Novartis|Eisai Inc.